Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Mailliard

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Journal of Pain and Symptom Management|February 1, 1997
Pilot study evaluating local anesthetics administered systemically for treatment of pain in patients with advanced cancerS F Chong, M E Bretscher, J A Mailliard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment GroupC G Moertel, L L Gunderson, J A Mailliard, et al.
American Journal of Clinical Oncology|April 1, 1990
Evaluation of trilostane plus hydrocortisone in women with metastatic breast cancer and prior hormonal therapy exposureJ N Ingle, J E Krook, D J Schaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trialT E Witzig, L Letendre, J Gerstner, et al.
Cancer|April 1, 1990
A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancerT E Elliott, C G Moertel, H S Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancerM J O'Connell, J A Mailliard, M J Kahn, et al.
Gynecologic Oncology|September 1, 1987
Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinomaJ H Edmonson, J E Krook, J F Hilton, et al.
Breast Cancer Research and Treatment|May 1, 1997
Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancerJ N Ingle, C G Kardinal, V J Suman, et al.
Medical and Pediatric Oncology|January 1, 1988
Phase II study of bisantrene administered by continuous 72-hour infusion for advanced pancreatic adenocarcinomaR F Marschke, L K Kvols, S A Cullinan, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 1, 2004
Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment GroupA Jatoi, N Foster, P Johnson, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Journal of Pain and Symptom Management|February 1, 1997
Pilot study evaluating local anesthetics administered systemically for treatment of pain in patients with advanced cancerS F Chong, M E Bretscher, J A Mailliard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment GroupC G Moertel, L L Gunderson, J A Mailliard, et al.
American Journal of Clinical Oncology|April 1, 1990
Evaluation of trilostane plus hydrocortisone in women with metastatic breast cancer and prior hormonal therapy exposureJ N Ingle, J E Krook, D J Schaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trialT E Witzig, L Letendre, J Gerstner, et al.
Cancer|April 1, 1990
A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancerT E Elliott, C G Moertel, H S Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancerM J O'Connell, J A Mailliard, M J Kahn, et al.
Gynecologic Oncology|September 1, 1987
Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinomaJ H Edmonson, J E Krook, J F Hilton, et al.
Breast Cancer Research and Treatment|May 1, 1997
Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancerJ N Ingle, C G Kardinal, V J Suman, et al.
Medical and Pediatric Oncology|January 1, 1988
Phase II study of bisantrene administered by continuous 72-hour infusion for advanced pancreatic adenocarcinomaR F Marschke, L K Kvols, S A Cullinan, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 1, 2004
Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment GroupA Jatoi, N Foster, P Johnson, et al.
Pageof 10